Origins - Inside Venture Capital, Hosted by a GP and an LP
Ciaran O'Leary, BlueYard
Apr 14, 2020
Ciaran O'Leary, co-founder of BlueYard VC, discusses the evolution of European tech and VC, adapting to Covid-19, and investing in revolutionary companies like Meatable and Bit Bio. BlueYard's focus on a new internet stack, financial liberty, and nature as a technology sets them apart in the VC landscape.
49:07
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Blue Yard's investment in BitBio reflects their focus on groundbreaking technologies with industry-wide impact.
- Blue Yard's boutique model prioritizes intellectual curiosity, personalized approach, and stability during economic uncertainty.
Deep dives
Impressive Portfolio Companies and Their Technologies
Blue Yard's investment in BitBio, a UK-based company, stands out as an innovative platform enabling stem cell programming, potentially revolutionizing animal-free food and materials production, as well as cell therapies by differentiating stem cells into various cell types. This technological advancement aligns with Blue Yard's focus on fundamental and groundbreaking technologies with far-reaching implications across industry sectors.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
